Hepatitis C inhibitor compounds
US7939667B2 · kind B2 · utility
16Cited by
35References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2007 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Jul 17, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I):wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.